Durable complete responses off all treatment in patients with metastatic malignant melanoma after sequential immunotherapy followed by a finite course of BRAF inhibitor therapy-Reference-Cited by-同舟云学术

Durable complete responses off all treatment in patients with metastatic malignant melanoma after sequential immunotherapy followed by a finite course of BRAF inhibitor therapy

Published:2015-03-25 Issue:5 Volume:16 Page:662-670
ISSN:1538-4047
Container-title:Cancer Biology & Therapy
language:en
Short-container-title:Cancer Biology & Therapy

Author:

Wyluda Edward J,Cheng Jihua,Schell Todd D,Haley Jeremy S,Mallon Carol,Neves Rogerio I,Robertson Gavin,Sivik Jeffrey,Mackley Heath,Talamo Giampaolo,Drabick Joseph J

Publisher

Informa UK Limited

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1080/15384047.2015.1026507

Reference48 articles.

1. Treatment of Metastatic Melanoma Using Interleukin-2 Alone or in Conjunction with Vaccines

2. High-Dose Recombinant Interleukin 2 Therapy for Patients With Metastatic Melanoma: Analysis of 270 Patients Treated Between 1985 and 1993

3. Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

4. High-dose Interleukin 2-induced Myocarditis

5. Inhibition of Mutated, Activated BRAF in Metastatic Melanoma

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Resistance, rebound, and recurrence regrowth patterns in pediatric low-grade glioma treated by MAPK inhibition: A modified Delphi approach to build international consensus-based definitions—International Pediatric Low-Grade Glioma Coalition;Neuro-Oncology;2024-05-14

2. BRAF inhibitor cessation prior to disease progression in metastatic melanoma: Long-term outcomes;European Journal of Cancer;2023-01

3. Discontinuation of BRAF/MEK-Directed Targeted Therapy after Complete Remission of Metastatic Melanoma—A Retrospective Multicenter ADOReg Study;Cancers;2021-05-12

4. A case of sudden brain metastases progression after temporary targeted therapy discontinuation: when to regret a drug holiday;Melanoma Research;2021-02-18

5. PD-L1 Detection on Circulating Melanoma Cells;Methods in Molecular Biology;2021